AHA GUIDELINES Bundle (free trial)

Lower Extremity Peripheral Artery Disease 2024

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1521560

Contents of this Issue

Navigation

Page 36 of 55

37 YES NO YES NO Risk-benefit assessment: do potential benefits of revascularization (QOL, walking performance, functional status) outweigh risks? (1) Revascularization is not recommended (3: No benefit) Effectiveness of endovascular revascularization is unknown (2b) Endovascular approaches may be considered if patient is high risk for surgery and/or anatomic factors are favorable (2a) Effectiveness of surgical revascularization is unknown (2b) Endarterectomy is reasonable, particularly to preserve profunda femoris artery pathways (2a) Hemodynamically significant common femoral artery disease Hemodynamically significant isolated infrapopliteal disease Continue GDMT including structured exercise (1)

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Lower Extremity Peripheral Artery Disease 2024